

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.20501901 |
| 2 | axon ensheathment (GO:0008366) | 6.07390681 |
| 3 | ensheathment of neurons (GO:0007272) | 6.07390681 |
| 4 | myelination (GO:0042552) | 5.97905362 |
| 5 | myelin maintenance (GO:0043217) | 5.73417593 |
| 6 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.10745045 |
| 7 | response to methylmercury (GO:0051597) | 5.00067771 |
| 8 | creatine metabolic process (GO:0006600) | 4.77258952 |
| 9 | synaptic vesicle maturation (GO:0016188) | 4.62427798 |
| 10 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.32076996 |
| 11 | amyloid precursor protein metabolic process (GO:0042982) | 4.24082934 |
| 12 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.23768269 |
| 13 | establishment of mitochondrion localization (GO:0051654) | 4.23208899 |
| 14 | cholesterol biosynthetic process (GO:0006695) | 4.07391401 |
| 15 | negative regulation of protein localization to cell surface (GO:2000009) | 3.99349256 |
| 16 | oligodendrocyte differentiation (GO:0048709) | 3.99043092 |
| 17 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.90800945 |
| 18 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.90383990 |
| 19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.89889306 |
| 20 | negative regulation of neurotransmitter transport (GO:0051589) | 3.83319434 |
| 21 | regulation of collateral sprouting (GO:0048670) | 3.80317294 |
| 22 | regulation of lipoprotein metabolic process (GO:0050746) | 3.76418280 |
| 23 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.73577925 |
| 24 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.72973451 |
| 25 | proline transport (GO:0015824) | 3.71130652 |
| 26 | glutamate secretion (GO:0014047) | 3.69718202 |
| 27 | import into cell (GO:0098657) | 3.69060294 |
| 28 | response to lipoprotein particle (GO:0055094) | 3.67102830 |
| 29 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.66421856 |
| 30 | L-amino acid import (GO:0043092) | 3.62681707 |
| 31 | sterol biosynthetic process (GO:0016126) | 3.59479673 |
| 32 | neuronal action potential propagation (GO:0019227) | 3.55672360 |
| 33 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.55394719 |
| 34 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.53588461 |
| 35 | astrocyte development (GO:0014002) | 3.50208049 |
| 36 | membrane tubulation (GO:0097320) | 3.50158373 |
| 37 | amyloid precursor protein catabolic process (GO:0042987) | 3.42319295 |
| 38 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.41876329 |
| 39 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.39838275 |
| 40 | adhesion of symbiont to host cell (GO:0044650) | 3.36386530 |
| 41 | virion attachment to host cell (GO:0019062) | 3.36386530 |
| 42 | synaptic vesicle exocytosis (GO:0016079) | 3.33884899 |
| 43 | cellular potassium ion homeostasis (GO:0030007) | 3.33734953 |
| 44 | very long-chain fatty acid metabolic process (GO:0000038) | 3.33321169 |
| 45 | dendritic spine morphogenesis (GO:0060997) | 3.28374446 |
| 46 | eye photoreceptor cell differentiation (GO:0001754) | 3.27073940 |
| 47 | photoreceptor cell differentiation (GO:0046530) | 3.27073940 |
| 48 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.22489539 |
| 49 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.22489539 |
| 50 | neuron remodeling (GO:0016322) | 3.22185242 |
| 51 | gamma-aminobutyric acid transport (GO:0015812) | 3.19795456 |
| 52 | glycosylceramide metabolic process (GO:0006677) | 3.18728600 |
| 53 | positive regulation of meiosis (GO:0045836) | 3.18337520 |
| 54 | substantia nigra development (GO:0021762) | 3.17405336 |
| 55 | cytochrome complex assembly (GO:0017004) | 3.16725357 |
| 56 | neurotransmitter secretion (GO:0007269) | 3.16504849 |
| 57 | isoprenoid biosynthetic process (GO:0008299) | 3.15340924 |
| 58 | apical protein localization (GO:0045176) | 3.15102420 |
| 59 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.15053276 |
| 60 | protein palmitoylation (GO:0018345) | 3.14714126 |
| 61 | respiratory chain complex IV assembly (GO:0008535) | 3.14234288 |
| 62 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.13183128 |
| 63 | thioester biosynthetic process (GO:0035384) | 3.12404478 |
| 64 | acyl-CoA biosynthetic process (GO:0071616) | 3.12404478 |
| 65 | inositol phosphate catabolic process (GO:0071545) | 3.11935992 |
| 66 | regulation of oxidative phosphorylation (GO:0002082) | 3.09596820 |
| 67 | potassium ion homeostasis (GO:0055075) | 3.04519612 |
| 68 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.04469292 |
| 69 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.04469292 |
| 70 | glycerophospholipid catabolic process (GO:0046475) | 3.03818055 |
| 71 | detection of calcium ion (GO:0005513) | 3.03460275 |
| 72 | startle response (GO:0001964) | 3.01668950 |
| 73 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.01127727 |
| 74 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.00951424 |
| 75 | asymmetric protein localization (GO:0008105) | 2.99455656 |
| 76 | response to pheromone (GO:0019236) | 2.99181223 |
| 77 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.98928400 |
| 78 | magnesium ion transport (GO:0015693) | 2.98901792 |
| 79 | auditory receptor cell stereocilium organization (GO:0060088) | 2.98375726 |
| 80 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.97335218 |
| 81 | protein complex biogenesis (GO:0070271) | 2.97108970 |
| 82 | alanine transport (GO:0032328) | 2.96857179 |
| 83 | L-fucose catabolic process (GO:0042355) | 2.95745491 |
| 84 | fucose catabolic process (GO:0019317) | 2.95745491 |
| 85 | L-fucose metabolic process (GO:0042354) | 2.95745491 |
| 86 | C4-dicarboxylate transport (GO:0015740) | 2.95631915 |
| 87 | regulation of neurotransmitter uptake (GO:0051580) | 2.95614666 |
| 88 | axon development (GO:0061564) | 2.94193512 |
| 89 | righting reflex (GO:0060013) | 2.92832468 |
| 90 | positive regulation of meiotic cell cycle (GO:0051446) | 2.92272979 |
| 91 | protein localization to endosome (GO:0036010) | 2.88738424 |
| 92 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.87239889 |
| 93 | neuromuscular process controlling posture (GO:0050884) | 2.86376698 |
| 94 | potassium ion import (GO:0010107) | 2.85281344 |
| 95 | response to lead ion (GO:0010288) | 2.83890017 |
| 96 | response to dietary excess (GO:0002021) | 2.82202327 |
| 97 | regulation of synapse structural plasticity (GO:0051823) | 2.81713492 |
| 98 | neurotransmitter transport (GO:0006836) | 2.80996418 |
| 99 | GPI anchor biosynthetic process (GO:0006506) | 2.79499428 |
| 100 | synaptic transmission, glutamatergic (GO:0035249) | 2.77373510 |
| 101 | presynaptic membrane assembly (GO:0097105) | 2.77220280 |
| 102 | peptidyl-cysteine modification (GO:0018198) | 2.77090424 |
| 103 | regulation of neurotransmitter levels (GO:0001505) | 2.76340797 |
| 104 | adult walking behavior (GO:0007628) | 2.76335073 |
| 105 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.75919491 |
| 106 | membrane raft organization (GO:0031579) | 2.75499322 |
| 107 | regulation of dendritic spine development (GO:0060998) | 2.75433839 |
| 108 | response to redox state (GO:0051775) | 2.74946376 |
| 109 | amino acid import (GO:0043090) | 2.74832482 |
| 110 | detection of temperature stimulus (GO:0016048) | 2.73664973 |
| 111 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.73520647 |
| 112 | neuron-neuron synaptic transmission (GO:0007270) | 2.72561534 |
| 113 | regulation of synaptic vesicle transport (GO:1902803) | 2.72027653 |
| 114 | presynaptic membrane organization (GO:0097090) | 2.71975281 |
| 115 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.71523878 |
| 116 | cellular ketone body metabolic process (GO:0046950) | 2.67989807 |
| 117 | glutamate receptor signaling pathway (GO:0007215) | 2.67222336 |
| 118 | GPI anchor metabolic process (GO:0006505) | 2.66099405 |
| 119 | cellular potassium ion transport (GO:0071804) | 2.64394073 |
| 120 | potassium ion transmembrane transport (GO:0071805) | 2.64394073 |
| 121 | potassium ion transport (GO:0006813) | 2.64319341 |
| 122 | membrane depolarization during action potential (GO:0086010) | 2.64164179 |
| 123 | adhesion of symbiont to host (GO:0044406) | 2.63956880 |
| 124 | calcium ion-dependent exocytosis (GO:0017156) | 2.63670539 |
| 125 | neurotransmitter uptake (GO:0001504) | 2.63472050 |
| 126 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.61922726 |
| 127 | negative regulation of axonogenesis (GO:0050771) | 2.60917947 |
| 128 | serotonin metabolic process (GO:0042428) | 2.60490026 |
| 129 | nerve growth factor signaling pathway (GO:0038180) | 2.59665658 |
| 130 | regulation of neurotransmitter transport (GO:0051588) | 2.59513495 |
| 131 | glycosphingolipid biosynthetic process (GO:0006688) | 2.59506733 |
| 132 | postsynaptic membrane organization (GO:0001941) | 2.57823642 |
| 133 | regulation of autophagic vacuole assembly (GO:2000785) | 2.57066793 |
| 134 | tissue regeneration (GO:0042246) | 2.56021460 |
| 135 | positive regulation of glial cell differentiation (GO:0045687) | 2.55969860 |
| 136 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.55450565 |
| 137 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.54735784 |
| 138 | auditory behavior (GO:0031223) | 2.54106847 |
| 139 | protein polyglutamylation (GO:0018095) | 2.53595181 |
| 140 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.53289044 |
| 141 | negative regulation of cation channel activity (GO:2001258) | 2.53067596 |
| 142 | transmission of nerve impulse (GO:0019226) | 2.53014699 |
| 143 | glycine transport (GO:0015816) | 2.52604545 |
| 144 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.52095672 |
| 145 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.52019753 |
| 146 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.51066366 |
| 147 | inositol phosphate dephosphorylation (GO:0046855) | 2.51066366 |
| 148 | insulin secretion (GO:0030073) | 2.50898554 |
| 149 | myelination in peripheral nervous system (GO:0022011) | 2.50775909 |
| 150 | peripheral nervous system axon ensheathment (GO:0032292) | 2.50775909 |
| 151 | primary amino compound metabolic process (GO:1901160) | 2.50536251 |
| 152 | positive regulation of gliogenesis (GO:0014015) | 2.49981333 |
| 153 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.49443266 |
| 154 | acidic amino acid transport (GO:0015800) | 2.49351589 |
| 155 | platelet dense granule organization (GO:0060155) | 2.48735965 |
| 156 | negative regulation of acute inflammatory response (GO:0002674) | 2.48566624 |
| 157 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.48298062 |
| 158 | xenobiotic catabolic process (GO:0042178) | 2.47867751 |
| 159 | retinal cone cell development (GO:0046549) | 2.46666214 |
| 160 | ketone body metabolic process (GO:1902224) | 2.46598334 |
| 161 | negative regulation of dendrite development (GO:2000171) | 2.45365249 |
| 162 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.45316393 |
| 163 | membrane repolarization (GO:0086009) | 2.45144607 |
| 164 | regulation of vacuole organization (GO:0044088) | 2.45053077 |
| 165 | enteric nervous system development (GO:0048484) | 2.44874335 |
| 166 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.44575096 |
| 167 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.44030705 |
| 168 | glutathione biosynthetic process (GO:0006750) | 2.43967670 |
| 169 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.43961206 |
| 170 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.43921310 |
| 171 | chemosensory behavior (GO:0007635) | 2.43619280 |
| 172 | regulation of neurotransmitter secretion (GO:0046928) | 2.43311419 |
| 173 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.43271177 |
| 174 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.42216074 |
| 175 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.41918940 |
| 176 | glial cell development (GO:0021782) | 2.41150399 |
| 177 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.40835864 |
| 178 | regulation of postsynaptic membrane potential (GO:0060078) | 2.40482181 |
| 179 | DNA deamination (GO:0045006) | 2.40096839 |
| 180 | Golgi to endosome transport (GO:0006895) | 2.39078400 |
| 181 | neuromuscular synaptic transmission (GO:0007274) | 2.38513598 |
| 182 | triglyceride biosynthetic process (GO:0019432) | 2.36395491 |
| 183 | cortical actin cytoskeleton organization (GO:0030866) | 2.33969303 |
| 184 | extracellular matrix assembly (GO:0085029) | 2.33079150 |
| 185 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.32123084 |
| 186 | cofactor catabolic process (GO:0051187) | 2.32085479 |
| 187 | cellular response to epinephrine stimulus (GO:0071872) | 2.31559070 |
| 188 | cholesterol metabolic process (GO:0008203) | 2.31348739 |
| 189 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.29349158 |
| 190 | L-phenylalanine catabolic process (GO:0006559) | 2.29349158 |
| 191 | axon ensheathment in central nervous system (GO:0032291) | 10.6300399 |
| 192 | central nervous system myelination (GO:0022010) | 10.6300399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.08916810 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.65111212 |
| 3 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.53973135 |
| 4 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.35078701 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.33217838 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.29020807 |
| 7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.27013048 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.25754752 |
| 9 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.24729452 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.22162586 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.12466187 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.08509646 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.07876913 |
| 14 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.99278214 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.93991300 |
| 16 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.89280317 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.87713795 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.84869263 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.75776503 |
| 20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.75776503 |
| 21 | P300_19829295_ChIP-Seq_ESCs_Human | 1.71943091 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.71653337 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.70961914 |
| 24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.68517793 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.68084470 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.67006796 |
| 27 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.66308612 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.65502413 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.65369878 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.59957395 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59266288 |
| 32 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.57312918 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56876948 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.56628219 |
| 35 | GATA1_19941826_ChIP-Seq_K562_Human | 1.54989702 |
| 36 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.54952908 |
| 37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54932773 |
| 38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.54796998 |
| 39 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.50798419 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.48713406 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.47792081 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47569572 |
| 43 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47287565 |
| 44 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.45999784 |
| 45 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.45368590 |
| 46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42193713 |
| 47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.42099297 |
| 48 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.41750280 |
| 49 | AR_25329375_ChIP-Seq_VCAP_Human | 1.41580760 |
| 50 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.39313841 |
| 51 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38737514 |
| 52 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38737514 |
| 53 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.36032035 |
| 54 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.35359498 |
| 55 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.34747720 |
| 56 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.33364786 |
| 57 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.31323738 |
| 58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31024453 |
| 59 | EWS_26573619_Chip-Seq_HEK293_Human | 1.29524669 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29378458 |
| 61 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29167454 |
| 62 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.28057215 |
| 63 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.25850109 |
| 64 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.25434962 |
| 65 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25410262 |
| 66 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.24886306 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24578330 |
| 68 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23437575 |
| 69 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.21202535 |
| 70 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.19629113 |
| 71 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.19629113 |
| 72 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.19227051 |
| 73 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17824965 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17708458 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17624279 |
| 76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16205122 |
| 77 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15905078 |
| 78 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.14386444 |
| 79 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.13184513 |
| 80 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12103803 |
| 81 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.11107739 |
| 82 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.10392951 |
| 83 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.09852789 |
| 84 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.09783627 |
| 85 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09097863 |
| 86 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08881189 |
| 87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08757822 |
| 88 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08370397 |
| 89 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.08092533 |
| 90 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.08092533 |
| 91 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08004621 |
| 92 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.07832271 |
| 93 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06655142 |
| 94 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06549242 |
| 95 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.06326840 |
| 96 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06097451 |
| 97 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05719747 |
| 98 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05417690 |
| 99 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05398732 |
| 100 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.03987451 |
| 101 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03529716 |
| 102 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.03087221 |
| 103 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.03030555 |
| 104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02981299 |
| 105 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.02915972 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02872676 |
| 107 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02713801 |
| 108 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02589303 |
| 109 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02253411 |
| 110 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.02078812 |
| 111 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01842213 |
| 112 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.01503675 |
| 113 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00791839 |
| 114 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00761668 |
| 115 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00609291 |
| 116 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99656567 |
| 117 | NCOR_22424771_ChIP-Seq_293T_Human | 0.99375929 |
| 118 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.99316523 |
| 119 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98034823 |
| 120 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97807476 |
| 121 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96996485 |
| 122 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96599140 |
| 123 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.96447979 |
| 124 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.95986145 |
| 125 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93856580 |
| 126 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93670227 |
| 127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92985252 |
| 128 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92905125 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92619564 |
| 130 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.91415967 |
| 131 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91240905 |
| 132 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.90744033 |
| 133 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90268962 |
| 134 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90238886 |
| 135 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.89980588 |
| 136 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89489189 |
| 137 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.87571534 |
| 138 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87288395 |
| 139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87056949 |
| 140 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.84686768 |
| 141 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.82032026 |
| 142 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.80826971 |
| 143 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80519881 |
| 144 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.80021098 |
| 145 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79842466 |
| 146 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.79457174 |
| 147 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.78896642 |
| 148 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.78081619 |
| 149 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.76409376 |
| 150 | KDM2B_26808549_Chip-Seq_K562_Human | 0.76114224 |
| 151 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.75455123 |
| 152 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.75455123 |
| 153 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.74909806 |
| 154 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.74893584 |
| 155 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.74855490 |
| 156 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.74626798 |
| 157 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.74352622 |
| 158 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74195339 |
| 159 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.73887193 |
| 160 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.73465995 |
| 161 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.73170108 |
| 162 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.73162795 |
| 163 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.72697423 |
| 164 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.72454026 |
| 165 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.72275604 |
| 166 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.72265542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.55716302 |
| 2 | MP0003950_abnormal_plasma_membrane | 3.51311119 |
| 3 | MP0003690_abnormal_glial_cell | 3.50757649 |
| 4 | MP0003329_amyloid_beta_deposits | 3.33206212 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.75825124 |
| 6 | MP0005646_abnormal_pituitary_gland | 2.70052643 |
| 7 | MP0003880_abnormal_central_pattern | 2.68242173 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.67531010 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.62219664 |
| 10 | MP0004270_analgesia | 2.57702116 |
| 11 | MP0003634_abnormal_glial_cell | 2.48918420 |
| 12 | MP0000604_amyloidosis | 2.32492832 |
| 13 | MP0003787_abnormal_imprinting | 2.29713225 |
| 14 | MP0004885_abnormal_endolymph | 2.16716580 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.11969794 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.09832477 |
| 17 | MP0001905_abnormal_dopamine_level | 2.07832912 |
| 18 | MP0005171_absent_coat_pigmentation | 2.07151996 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.06275407 |
| 20 | MP0002272_abnormal_nervous_system | 2.05247548 |
| 21 | MP0001529_abnormal_vocalization | 2.04120714 |
| 22 | MP0004043_abnormal_pH_regulation | 2.02046733 |
| 23 | MP0004142_abnormal_muscle_tone | 1.97549307 |
| 24 | MP0004742_abnormal_vestibular_system | 1.90958695 |
| 25 | MP0002064_seizures | 1.89120898 |
| 26 | MP0009840_abnormal_foam_cell | 1.88734621 |
| 27 | MP0002736_abnormal_nociception_after | 1.88643412 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.86660379 |
| 29 | MP0001486_abnormal_startle_reflex | 1.83916070 |
| 30 | MP0010386_abnormal_urinary_bladder | 1.81387786 |
| 31 | MP0002229_neurodegeneration | 1.80552830 |
| 32 | MP0008260_abnormal_autophagy | 1.79829733 |
| 33 | MP0006082_CNS_inflammation | 1.74988969 |
| 34 | MP0000372_irregular_coat_pigmentation | 1.66678408 |
| 35 | MP0002638_abnormal_pupillary_reflex | 1.62931041 |
| 36 | MP0003632_abnormal_nervous_system | 1.61882551 |
| 37 | MP0004859_abnormal_synaptic_plasticity | 1.61547181 |
| 38 | MP0003011_delayed_dark_adaptation | 1.60723459 |
| 39 | MP0004147_increased_porphyrin_level | 1.60027722 |
| 40 | MP0003633_abnormal_nervous_system | 1.58625536 |
| 41 | MP0001984_abnormal_olfaction | 1.54154214 |
| 42 | MP0003806_abnormal_nucleotide_metabolis | 1.53879103 |
| 43 | MP0008872_abnormal_physiological_respon | 1.52613604 |
| 44 | MP0003631_nervous_system_phenotype | 1.50703568 |
| 45 | MP0005167_abnormal_blood-brain_barrier | 1.50104292 |
| 46 | MP0005253_abnormal_eye_physiology | 1.50090840 |
| 47 | MP0000747_muscle_weakness | 1.46671986 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.46574254 |
| 49 | MP0005410_abnormal_fertilization | 1.42851126 |
| 50 | MP0003879_abnormal_hair_cell | 1.42257777 |
| 51 | MP0005409_darkened_coat_color | 1.41936550 |
| 52 | MP0003136_yellow_coat_color | 1.41598129 |
| 53 | MP0003075_altered_response_to | 1.41298898 |
| 54 | MP0002557_abnormal_social/conspecific_i | 1.39083028 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.38795361 |
| 56 | MP0002734_abnormal_mechanical_nocicepti | 1.36810995 |
| 57 | MP0002909_abnormal_adrenal_gland | 1.36509934 |
| 58 | MP0003195_calcinosis | 1.35514418 |
| 59 | MP0001986_abnormal_taste_sensitivity | 1.33667300 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 1.33616293 |
| 61 | MP0001970_abnormal_pain_threshold | 1.31629947 |
| 62 | MP0002735_abnormal_chemical_nociception | 1.31334475 |
| 63 | MP0001958_emphysema | 1.29254056 |
| 64 | MP0009046_muscle_twitch | 1.28968416 |
| 65 | MP0008569_lethality_at_weaning | 1.27468422 |
| 66 | MP0005423_abnormal_somatic_nervous | 1.26834550 |
| 67 | MP0006072_abnormal_retinal_apoptosis | 1.25767487 |
| 68 | MP0005451_abnormal_body_composition | 1.23145580 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 1.22614758 |
| 70 | MP0003635_abnormal_synaptic_transmissio | 1.21440727 |
| 71 | MP0002090_abnormal_vision | 1.19894865 |
| 72 | MP0002102_abnormal_ear_morphology | 1.19845729 |
| 73 | MP0005551_abnormal_eye_electrophysiolog | 1.19108949 |
| 74 | MP0010678_abnormal_skin_adnexa | 1.17941057 |
| 75 | MP0001485_abnormal_pinna_reflex | 1.17843993 |
| 76 | MP0009745_abnormal_behavioral_response | 1.17265242 |
| 77 | MP0001851_eye_inflammation | 1.16685371 |
| 78 | MP0006054_spinal_hemorrhage | 1.14860553 |
| 79 | MP0005174_abnormal_tail_pigmentation | 1.13143588 |
| 80 | MP0004381_abnormal_hair_follicle | 1.12809664 |
| 81 | MP0000778_abnormal_nervous_system | 1.12023996 |
| 82 | MP0004215_abnormal_myocardial_fiber | 1.10604356 |
| 83 | MP0003283_abnormal_digestive_organ | 1.10544714 |
| 84 | MP0002733_abnormal_thermal_nociception | 1.10285631 |
| 85 | MP0003137_abnormal_impulse_conducting | 1.10195521 |
| 86 | MP0002295_abnormal_pulmonary_circulatio | 1.09562156 |
| 87 | MP0000955_abnormal_spinal_cord | 1.08886848 |
| 88 | MP0006276_abnormal_autonomic_nervous | 1.08358301 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 1.04316604 |
| 90 | MP0004134_abnormal_chest_morphology | 1.04025710 |
| 91 | MP0008875_abnormal_xenobiotic_pharmacok | 1.03793984 |
| 92 | MP0001502_abnormal_circadian_rhythm | 1.02902805 |
| 93 | MP0000749_muscle_degeneration | 1.02680204 |
| 94 | MP0003186_abnormal_redox_activity | 1.01658546 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 1.01038906 |
| 96 | MP0005535_abnormal_body_temperature | 1.00801790 |
| 97 | MP0002066_abnormal_motor_capabilities/c | 1.00513705 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99719847 |
| 99 | MP0000383_abnormal_hair_follicle | 0.98041440 |
| 100 | MP0002882_abnormal_neuron_morphology | 0.97954944 |
| 101 | MP0004858_abnormal_nervous_system | 0.97738402 |
| 102 | MP0001756_abnormal_urination | 0.94315156 |
| 103 | MP0005623_abnormal_meninges_morphology | 0.93393976 |
| 104 | MP0004185_abnormal_adipocyte_glucose | 0.90492698 |
| 105 | MP0004036_abnormal_muscle_relaxation | 0.89959190 |
| 106 | MP0005645_abnormal_hypothalamus_physiol | 0.89789063 |
| 107 | MP0002572_abnormal_emotion/affect_behav | 0.89367273 |
| 108 | MP0010234_abnormal_vibrissa_follicle | 0.89054556 |
| 109 | MP0001944_abnormal_pancreas_morphology | 0.88144227 |
| 110 | MP0002118_abnormal_lipid_homeostasis | 0.86373235 |
| 111 | MP0003191_abnormal_cellular_cholesterol | 0.86251678 |
| 112 | MP0000003_abnormal_adipose_tissue | 0.85756905 |
| 113 | MP0004811_abnormal_neuron_physiology | 0.85671275 |
| 114 | MP0001440_abnormal_grooming_behavior | 0.84873918 |
| 115 | MP0001348_abnormal_lacrimal_gland | 0.83476145 |
| 116 | MP0005083_abnormal_biliary_tract | 0.83208097 |
| 117 | MP0005195_abnormal_posterior_eye | 0.81121079 |
| 118 | MP0004085_abnormal_heartbeat | 0.81010001 |
| 119 | MP0002163_abnormal_gland_morphology | 0.80625819 |
| 120 | MP0002063_abnormal_learning/memory/cond | 0.80443441 |
| 121 | MP0004019_abnormal_vitamin_homeostasis | 0.80179143 |
| 122 | MP0002067_abnormal_sensory_capabilities | 0.77966628 |
| 123 | MP0000427_abnormal_hair_cycle | 0.77805192 |
| 124 | MP0001963_abnormal_hearing_physiology | 0.77309165 |
| 125 | MP0000015_abnormal_ear_pigmentation | 0.75607147 |
| 126 | MP0005164_abnormal_response_to | 0.75588436 |
| 127 | MP0002752_abnormal_somatic_nervous | 0.74674386 |
| 128 | MP0000462_abnormal_digestive_system | 0.74614946 |
| 129 | MP0002933_joint_inflammation | 0.73086708 |
| 130 | MP0008775_abnormal_heart_ventricle | 0.72618324 |
| 131 | MP0004924_abnormal_behavior | 0.71915208 |
| 132 | MP0005386_behavior/neurological_phenoty | 0.71915208 |
| 133 | MP0005375_adipose_tissue_phenotype | 0.71784367 |
| 134 | MP0001299_abnormal_eye_distance/ | 0.71066549 |
| 135 | MP0010329_abnormal_lipoprotein_level | 0.70868546 |
| 136 | MP0000631_abnormal_neuroendocrine_gland | 0.70842201 |
| 137 | MP0001661_extended_life_span | 0.70483787 |
| 138 | MP0003303_peritoneal_inflammation | 0.70382653 |
| 139 | MP0006035_abnormal_mitochondrial_morpho | 0.69857615 |
| 140 | MP0008874_decreased_physiological_sensi | 0.69249826 |
| 141 | MP0000465_gastrointestinal_hemorrhage | 0.67219912 |
| 142 | MP0002133_abnormal_respiratory_system | 0.66517634 |
| 143 | MP0005388_respiratory_system_phenotype | 0.66517634 |
| 144 | MP0005165_increased_susceptibility_to | 0.64437327 |
| 145 | MP0001501_abnormal_sleep_pattern | 0.64321318 |
| 146 | MP0000647_abnormal_sebaceous_gland | 0.63727705 |
| 147 | MP0000343_altered_response_to | 0.63088697 |
| 148 | MP0002419_abnormal_innate_immunity | 0.62961643 |
| 149 | MP0005332_abnormal_amino_acid | 0.62771408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 6.85707227 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.36179792 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.36179792 |
| 4 | Cerebral inclusion bodies (HP:0100314) | 5.01542452 |
| 5 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.70862993 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 4.44401586 |
| 7 | Peripheral hypomyelination (HP:0007182) | 4.35950134 |
| 8 | Onion bulb formation (HP:0003383) | 4.06674766 |
| 9 | Abnormality of the corticospinal tract (HP:0002492) | 4.05337127 |
| 10 | Parakeratosis (HP:0001036) | 4.03150183 |
| 11 | Focal motor seizures (HP:0011153) | 3.94781395 |
| 12 | Axonal loss (HP:0003447) | 3.91730401 |
| 13 | Sensory axonal neuropathy (HP:0003390) | 3.82901534 |
| 14 | Cerebral hypomyelination (HP:0006808) | 3.65377492 |
| 15 | Focal seizures (HP:0007359) | 3.46262162 |
| 16 | Febrile seizures (HP:0002373) | 3.40138718 |
| 17 | Abnormal auditory evoked potentials (HP:0006958) | 3.30252635 |
| 18 | Progressive macrocephaly (HP:0004481) | 3.23128308 |
| 19 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.13884740 |
| 20 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.10230860 |
| 21 | Hemiparesis (HP:0001269) | 3.07878354 |
| 22 | Intention tremor (HP:0002080) | 3.07467817 |
| 23 | Slow saccadic eye movements (HP:0000514) | 3.06498073 |
| 24 | Increased cerebral lipofuscin (HP:0011813) | 3.06028652 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.01099968 |
| 26 | Spastic gait (HP:0002064) | 2.99752277 |
| 27 | Acute necrotizing encephalopathy (HP:0006965) | 2.93977155 |
| 28 | Insidious onset (HP:0003587) | 2.90806392 |
| 29 | Termporal pattern (HP:0011008) | 2.90806392 |
| 30 | Retinal dysplasia (HP:0007973) | 2.89896916 |
| 31 | Ankle clonus (HP:0011448) | 2.88919956 |
| 32 | Hypothermia (HP:0002045) | 2.87708299 |
| 33 | Dysmetria (HP:0001310) | 2.87357166 |
| 34 | Abnormality of glycolysis (HP:0004366) | 2.85225917 |
| 35 | Increased serum pyruvate (HP:0003542) | 2.85225917 |
| 36 | Clumsiness (HP:0002312) | 2.81244716 |
| 37 | Loss of speech (HP:0002371) | 2.80680905 |
| 38 | Abnormal drinking behavior (HP:0030082) | 2.77267706 |
| 39 | Polydipsia (HP:0001959) | 2.77267706 |
| 40 | Cerebral hemorrhage (HP:0001342) | 2.74342936 |
| 41 | Stridor (HP:0010307) | 2.73107999 |
| 42 | Spastic paraparesis (HP:0002313) | 2.72258483 |
| 43 | Hepatosplenomegaly (HP:0001433) | 2.71000460 |
| 44 | Spastic tetraparesis (HP:0001285) | 2.69717642 |
| 45 | Mitochondrial inheritance (HP:0001427) | 2.67364667 |
| 46 | Generalized tonic-clonic seizures (HP:0002069) | 2.65958016 |
| 47 | Atonic seizures (HP:0010819) | 2.64678902 |
| 48 | Progressive cerebellar ataxia (HP:0002073) | 2.64337634 |
| 49 | Epileptic encephalopathy (HP:0200134) | 2.64004947 |
| 50 | Leukodystrophy (HP:0002415) | 2.62874919 |
| 51 | Acute encephalopathy (HP:0006846) | 2.60510701 |
| 52 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.57155197 |
| 53 | Mutism (HP:0002300) | 2.52896999 |
| 54 | Gaze-evoked nystagmus (HP:0000640) | 2.51758137 |
| 55 | Increased CSF lactate (HP:0002490) | 2.51404866 |
| 56 | Alacrima (HP:0000522) | 2.50639095 |
| 57 | Neuronal loss in central nervous system (HP:0002529) | 2.48970516 |
| 58 | Increased circulating renin level (HP:0000848) | 2.48496204 |
| 59 | Hepatocellular necrosis (HP:0001404) | 2.48134733 |
| 60 | Congenital stationary night blindness (HP:0007642) | 2.46401302 |
| 61 | Ketoacidosis (HP:0001993) | 2.46358373 |
| 62 | Dialeptic seizures (HP:0011146) | 2.45105200 |
| 63 | Epileptiform EEG discharges (HP:0011182) | 2.44731515 |
| 64 | Hyperventilation (HP:0002883) | 2.42322006 |
| 65 | Hepatic necrosis (HP:0002605) | 2.41389724 |
| 66 | Scanning speech (HP:0002168) | 2.40362277 |
| 67 | Myokymia (HP:0002411) | 2.39059409 |
| 68 | Large for gestational age (HP:0001520) | 2.38826722 |
| 69 | Visual hallucinations (HP:0002367) | 2.35385733 |
| 70 | Pancreatic cysts (HP:0001737) | 2.34416711 |
| 71 | Abnormality of midbrain morphology (HP:0002418) | 2.34283861 |
| 72 | Molar tooth sign on MRI (HP:0002419) | 2.34283861 |
| 73 | Anxiety (HP:0000739) | 2.33444848 |
| 74 | Delusions (HP:0000746) | 2.32645902 |
| 75 | Muscle fiber splitting (HP:0003555) | 2.32494384 |
| 76 | EEG with generalized epileptiform discharges (HP:0011198) | 2.31934416 |
| 77 | Paraparesis (HP:0002385) | 2.31415944 |
| 78 | Progressive neurologic deterioration (HP:0002344) | 2.30977551 |
| 79 | CNS hypomyelination (HP:0003429) | 2.28713761 |
| 80 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.28457545 |
| 81 | Amyloidosis (HP:0011034) | 2.28004315 |
| 82 | Dysostosis multiplex (HP:0000943) | 2.26852196 |
| 83 | Attenuation of retinal blood vessels (HP:0007843) | 2.26596211 |
| 84 | Peripheral demyelination (HP:0011096) | 2.25986962 |
| 85 | Premature skin wrinkling (HP:0100678) | 2.25882650 |
| 86 | Hypokalemic alkalosis (HP:0001949) | 2.25856763 |
| 87 | True hermaphroditism (HP:0010459) | 2.25342613 |
| 88 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.24307596 |
| 89 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.24307596 |
| 90 | Abnormality of glycolipid metabolism (HP:0010969) | 2.24307596 |
| 91 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.22880130 |
| 92 | Vacuolated lymphocytes (HP:0001922) | 2.22310936 |
| 93 | Abolished electroretinogram (ERG) (HP:0000550) | 2.21957611 |
| 94 | Abnormality of macrophages (HP:0004311) | 2.21580020 |
| 95 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.21466855 |
| 96 | Abnormality of binocular vision (HP:0011514) | 2.20355888 |
| 97 | Diplopia (HP:0000651) | 2.20355888 |
| 98 | Abnormal eating behavior (HP:0100738) | 2.19996611 |
| 99 | Hypsarrhythmia (HP:0002521) | 2.18368478 |
| 100 | Pheochromocytoma (HP:0002666) | 2.18229283 |
| 101 | Megalencephaly (HP:0001355) | 2.17742640 |
| 102 | Metabolic alkalosis (HP:0200114) | 2.17684907 |
| 103 | Polyuria (HP:0000103) | 2.17058867 |
| 104 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.14910243 |
| 105 | Broad-based gait (HP:0002136) | 2.14445457 |
| 106 | Pancreatic fibrosis (HP:0100732) | 2.12922782 |
| 107 | Absence seizures (HP:0002121) | 2.12908407 |
| 108 | Foot dorsiflexor weakness (HP:0009027) | 2.11594936 |
| 109 | Nephronophthisis (HP:0000090) | 2.09735928 |
| 110 | Hamartoma of the eye (HP:0010568) | 2.08750229 |
| 111 | Muscular hypotonia of the trunk (HP:0008936) | 2.07423123 |
| 112 | Tongue fasciculations (HP:0001308) | 2.06735535 |
| 113 | Methylmalonic aciduria (HP:0012120) | 2.06573062 |
| 114 | Hypoplasia of the iris (HP:0007676) | 2.06456341 |
| 115 | Urinary incontinence (HP:0000020) | 2.04918746 |
| 116 | Infantile muscular hypotonia (HP:0008947) | 2.04513156 |
| 117 | Decreased central vision (HP:0007663) | 2.04162020 |
| 118 | Ketosis (HP:0001946) | 2.03470145 |
| 119 | Prolonged QT interval (HP:0001657) | 2.02984822 |
| 120 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.01294997 |
| 121 | Aplasia of the phalanges of the hand (HP:0009802) | 2.01294997 |
| 122 | Aplasia involving bones of the extremities (HP:0009825) | 2.01294997 |
| 123 | Neuroendocrine neoplasm (HP:0100634) | 2.00886306 |
| 124 | Abnormal gallbladder physiology (HP:0012438) | 2.00602755 |
| 125 | Cholecystitis (HP:0001082) | 2.00602755 |
| 126 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.99245898 |
| 127 | Abnormality of magnesium homeostasis (HP:0004921) | 1.99017960 |
| 128 | Polyphagia (HP:0002591) | 1.97258461 |
| 129 | Dysdiadochokinesis (HP:0002075) | 1.96788995 |
| 130 | Hypomagnesemia (HP:0002917) | 1.96293634 |
| 131 | Autoamputation (HP:0001218) | 1.96021837 |
| 132 | Intestinal atresia (HP:0011100) | 1.95187727 |
| 133 | Akinesia (HP:0002304) | 1.94951154 |
| 134 | Hyporeflexia of lower limbs (HP:0002600) | 1.94791003 |
| 135 | White forelock (HP:0002211) | 1.93093779 |
| 136 | Gowers sign (HP:0003391) | 1.92755765 |
| 137 | Lower limb muscle weakness (HP:0007340) | 1.92533747 |
| 138 | Progressive inability to walk (HP:0002505) | 1.91221741 |
| 139 | Hypoplastic pelvis (HP:0008839) | 1.91081190 |
| 140 | Status epilepticus (HP:0002133) | 1.90831066 |
| 141 | Limb dystonia (HP:0002451) | 1.90646266 |
| 142 | Patchy hypopigmentation of hair (HP:0011365) | 1.90644238 |
| 143 | Action tremor (HP:0002345) | 1.87712741 |
| 144 | Respiratory failure (HP:0002878) | 1.87044827 |
| 145 | Agitation (HP:0000713) | 1.86436782 |
| 146 | Abnormality of the foot musculature (HP:0001436) | 1.85887535 |
| 147 | 3-Methylglutaconic aciduria (HP:0003535) | 1.85231227 |
| 148 | Postural tremor (HP:0002174) | 1.84927917 |
| 149 | Ventricular fibrillation (HP:0001663) | 1.84919270 |
| 150 | Rapidly progressive (HP:0003678) | 1.84596235 |
| 151 | Split foot (HP:0001839) | 1.84212823 |
| 152 | Abnormality of macular pigmentation (HP:0008002) | 1.84142347 |
| 153 | Hammertoe (HP:0001765) | 1.83057671 |
| 154 | Methylmalonic acidemia (HP:0002912) | 1.82801886 |
| 155 | Synostosis involving the elbow (HP:0003938) | 1.82306080 |
| 156 | Humeroradial synostosis (HP:0003041) | 1.82306080 |
| 157 | Diminished movement (HP:0002374) | 1.82011120 |
| 158 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.81616349 |
| 159 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.81616349 |
| 160 | Absent septum pellucidum (HP:0001331) | 1.81088125 |
| 161 | Conjunctival hamartoma (HP:0100780) | 1.80919684 |
| 162 | Premature rupture of membranes (HP:0001788) | 1.80881412 |
| 163 | Hyperthyroidism (HP:0000836) | 1.80828142 |
| 164 | Morphological abnormality of the inner ear (HP:0011390) | 1.79999797 |
| 165 | Poor speech (HP:0002465) | 1.79526989 |
| 166 | Renal Fanconi syndrome (HP:0001994) | 1.79065303 |
| 167 | Anteriorly placed anus (HP:0001545) | 1.78345872 |
| 168 | Abnormal EKG (HP:0003115) | 1.78258441 |
| 169 | Choreoathetosis (HP:0001266) | 1.77994299 |
| 170 | Inability to walk (HP:0002540) | 1.77812679 |
| 171 | Thickened helices (HP:0000391) | 1.77679199 |
| 172 | Episodic fever (HP:0001954) | 1.76510318 |
| 173 | Generalized myoclonic seizures (HP:0002123) | 1.75739945 |
| 174 | Rigidity (HP:0002063) | 1.74780706 |
| 175 | Partial duplication of thumb phalanx (HP:0009944) | 1.74502058 |
| 176 | Difficulty running (HP:0009046) | 1.74422673 |
| 177 | Type II lissencephaly (HP:0007260) | 1.74373759 |
| 178 | Progressive microcephaly (HP:0000253) | 1.73762629 |
| 179 | Distal sensory impairment (HP:0002936) | 1.73234810 |
| 180 | Clonus (HP:0002169) | 1.72266994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.68272618 |
| 2 | FRK | 4.94817078 |
| 3 | OXSR1 | 4.20986761 |
| 4 | EPHB1 | 4.18400742 |
| 5 | MAPKAPK5 | 3.18537768 |
| 6 | DAPK2 | 3.05270995 |
| 7 | NTRK3 | 2.99455309 |
| 8 | PLK2 | 2.88434264 |
| 9 | PBK | 2.73132423 |
| 10 | WNK4 | 2.60361601 |
| 11 | PKN1 | 2.59310324 |
| 12 | CDK19 | 2.49820414 |
| 13 | MAP4K2 | 2.31766613 |
| 14 | TESK2 | 2.19772268 |
| 15 | LIMK1 | 2.18985400 |
| 16 | BMPR1B | 2.17643662 |
| 17 | NTRK1 | 2.16460577 |
| 18 | MET | 2.13149155 |
| 19 | WNK1 | 2.00275684 |
| 20 | WNK3 | 1.99509759 |
| 21 | MAPK13 | 1.75520308 |
| 22 | ACVR1B | 1.67644282 |
| 23 | FGFR2 | 1.66604764 |
| 24 | PRKD3 | 1.65876924 |
| 25 | UHMK1 | 1.55157369 |
| 26 | CSNK1G3 | 1.50812507 |
| 27 | BCR | 1.48621229 |
| 28 | ROCK2 | 1.44978707 |
| 29 | MINK1 | 1.43694501 |
| 30 | FGR | 1.40900665 |
| 31 | NUAK1 | 1.39105604 |
| 32 | CLK1 | 1.38660324 |
| 33 | CAMK2B | 1.36433994 |
| 34 | CSNK1A1L | 1.35601198 |
| 35 | DAPK1 | 1.35197861 |
| 36 | PAK6 | 1.29241464 |
| 37 | CAMK2D | 1.21764177 |
| 38 | FER | 1.19312438 |
| 39 | MUSK | 1.18911029 |
| 40 | PLK3 | 1.15860440 |
| 41 | SGK223 | 1.12285684 |
| 42 | SGK494 | 1.12285684 |
| 43 | KSR2 | 1.11787390 |
| 44 | TRIM28 | 1.11609502 |
| 45 | MAPKAPK3 | 1.10750826 |
| 46 | PHKG2 | 1.10658234 |
| 47 | PHKG1 | 1.10658234 |
| 48 | CSNK1G2 | 1.10403807 |
| 49 | PRKCG | 1.09839526 |
| 50 | TNK2 | 1.06198608 |
| 51 | TNIK | 1.05476059 |
| 52 | MARK2 | 1.04514350 |
| 53 | ARAF | 1.02374855 |
| 54 | BLK | 1.02352814 |
| 55 | CSNK1G1 | 1.02216706 |
| 56 | PRKD1 | 0.98071388 |
| 57 | VRK2 | 0.96901463 |
| 58 | CAMK1 | 0.95119459 |
| 59 | CAMK2G | 0.95003518 |
| 60 | PDPK1 | 0.92258634 |
| 61 | LMTK2 | 0.91660875 |
| 62 | PRPF4B | 0.91634653 |
| 63 | NEK6 | 0.91567996 |
| 64 | PRKCI | 0.91091292 |
| 65 | CAMKK2 | 0.89119164 |
| 66 | MST4 | 0.88823259 |
| 67 | TRPM7 | 0.88108769 |
| 68 | CDK14 | 0.87941681 |
| 69 | GRK5 | 0.87757733 |
| 70 | BRSK1 | 0.85795204 |
| 71 | MAP3K13 | 0.84187418 |
| 72 | MAP3K12 | 0.84096295 |
| 73 | MAP2K6 | 0.83307687 |
| 74 | CSF1R | 0.81192493 |
| 75 | TIE1 | 0.80656896 |
| 76 | EPHA4 | 0.79029025 |
| 77 | EIF2AK1 | 0.78692189 |
| 78 | CDK5 | 0.78478955 |
| 79 | DAPK3 | 0.78316058 |
| 80 | INSRR | 0.78127205 |
| 81 | BMX | 0.78126391 |
| 82 | STK11 | 0.77924335 |
| 83 | CDK15 | 0.74724555 |
| 84 | DYRK2 | 0.74011245 |
| 85 | PRKCQ | 0.73856354 |
| 86 | STK16 | 0.73651053 |
| 87 | EIF2AK3 | 0.72940282 |
| 88 | GRK7 | 0.70671378 |
| 89 | ZAK | 0.69981092 |
| 90 | MOS | 0.69430943 |
| 91 | CDK11A | 0.68102663 |
| 92 | TYRO3 | 0.67779118 |
| 93 | PAK3 | 0.66988386 |
| 94 | CDK18 | 0.65895495 |
| 95 | FYN | 0.65840406 |
| 96 | CAMK2A | 0.65811251 |
| 97 | FES | 0.63384542 |
| 98 | ICK | 0.63357160 |
| 99 | PRKCE | 0.63337105 |
| 100 | ADRBK1 | 0.62618504 |
| 101 | MAP2K1 | 0.61060186 |
| 102 | PRKCH | 0.60911468 |
| 103 | ERBB3 | 0.60657337 |
| 104 | ADRBK2 | 0.59633428 |
| 105 | NTRK2 | 0.57542421 |
| 106 | MAPK15 | 0.57442646 |
| 107 | SIK3 | 0.57156102 |
| 108 | CAMK1G | 0.56861611 |
| 109 | ROCK1 | 0.56565635 |
| 110 | MAP2K2 | 0.56503577 |
| 111 | GSK3A | 0.53405816 |
| 112 | PDK1 | 0.53044848 |
| 113 | ABL2 | 0.52659990 |
| 114 | KIT | 0.50846013 |
| 115 | AKT3 | 0.50289835 |
| 116 | MAP3K1 | 0.49829051 |
| 117 | MAP3K4 | 0.49144899 |
| 118 | PRKCA | 0.48514833 |
| 119 | PNCK | 0.47460916 |
| 120 | ILK | 0.46846340 |
| 121 | SGK2 | 0.46776624 |
| 122 | PRKACA | 0.46447597 |
| 123 | PTK2B | 0.46369550 |
| 124 | HIPK2 | 0.46366646 |
| 125 | PAK1 | 0.45698010 |
| 126 | PDK2 | 0.44715651 |
| 127 | RIPK4 | 0.44303966 |
| 128 | PRKG1 | 0.42805486 |
| 129 | BMPR2 | 0.42480055 |
| 130 | RPS6KA5 | 0.42434960 |
| 131 | PRKCZ | 0.42192450 |
| 132 | MAP2K7 | 0.42174993 |
| 133 | ERN1 | 0.41718465 |
| 134 | STK38 | 0.39134222 |
| 135 | PRKACB | 0.39026510 |
| 136 | CAMKK1 | 0.37774822 |
| 137 | PRKAA1 | 0.37115525 |
| 138 | BRSK2 | 0.36933582 |
| 139 | PINK1 | 0.36921035 |
| 140 | GRK1 | 0.36484794 |
| 141 | MAPK12 | 0.36337118 |
| 142 | PRKG2 | 0.36201115 |
| 143 | DMPK | 0.35862016 |
| 144 | BCKDK | 0.35276838 |
| 145 | DDR2 | 0.34485462 |
| 146 | MARK1 | 0.34371190 |
| 147 | CASK | 0.34228546 |
| 148 | IRAK2 | 0.34105025 |
| 149 | PAK2 | 0.33525987 |
| 150 | CSNK1A1 | 0.33325283 |
| 151 | LCK | 0.32833737 |
| 152 | SRC | 0.32050425 |
| 153 | RET | 0.31801485 |
| 154 | MAP3K2 | 0.31659307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.64105128 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.36443043 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.23183165 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.93224329 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.84752336 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.60029036 |
| 7 | Insulin secretion_Homo sapiens_hsa04911 | 2.48862423 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.45605148 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.40232111 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.30888993 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.19566998 |
| 12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.97878017 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 1.82416590 |
| 14 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.65020984 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.63807098 |
| 16 | Phototransduction_Homo sapiens_hsa04744 | 1.61261527 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.60594558 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.54250534 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.50025302 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.47573627 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.45058296 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.34722226 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.32724720 |
| 24 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.29764541 |
| 25 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.27592955 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.27566368 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.27491096 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.27441072 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23776268 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.23462627 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21970585 |
| 32 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.17002669 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15708834 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.14649428 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.12193343 |
| 36 | Alzheimers disease_Homo sapiens_hsa05010 | 1.11209674 |
| 37 | Taste transduction_Homo sapiens_hsa04742 | 1.08784633 |
| 38 | GABAergic synapse_Homo sapiens_hsa04727 | 1.08409203 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.08290341 |
| 40 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.07737128 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06803824 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05968776 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 1.00583316 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 0.99962231 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98810593 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98656405 |
| 47 | Olfactory transduction_Homo sapiens_hsa04740 | 0.98091301 |
| 48 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96923723 |
| 49 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.94133622 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.90973788 |
| 51 | Proteasome_Homo sapiens_hsa03050 | 0.90171211 |
| 52 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.89032643 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.87772947 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.87417206 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87106623 |
| 56 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.86434801 |
| 57 | Endocytosis_Homo sapiens_hsa04144 | 0.85682539 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85012835 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84209881 |
| 60 | Huntingtons disease_Homo sapiens_hsa05016 | 0.82701561 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.82614842 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82173193 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80206308 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.78410352 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78193246 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77160008 |
| 67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.76909818 |
| 68 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76299948 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76224485 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76000605 |
| 71 | Mineral absorption_Homo sapiens_hsa04978 | 0.75863574 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75495422 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74653718 |
| 74 | Morphine addiction_Homo sapiens_hsa05032 | 0.74579350 |
| 75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.73232629 |
| 76 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.72726696 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72650993 |
| 78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71308167 |
| 79 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.70510565 |
| 80 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67701319 |
| 81 | Long-term depression_Homo sapiens_hsa04730 | 0.67486984 |
| 82 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65889727 |
| 83 | RNA polymerase_Homo sapiens_hsa03020 | 0.65745372 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65481942 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64343568 |
| 86 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.64230392 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63956178 |
| 88 | Salivary secretion_Homo sapiens_hsa04970 | 0.63421258 |
| 89 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63164676 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62621834 |
| 91 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62421234 |
| 92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.61907412 |
| 93 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61318508 |
| 94 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.60735316 |
| 95 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60505008 |
| 96 | Basal transcription factors_Homo sapiens_hsa03022 | 0.57602673 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55498312 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55027087 |
| 99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51802841 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50593557 |
| 101 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50592153 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48856549 |
| 103 | Circadian entrainment_Homo sapiens_hsa04713 | 0.48795250 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48047412 |
| 105 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.47483011 |
| 106 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47337130 |
| 107 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47245218 |
| 108 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.46616861 |
| 109 | Renin secretion_Homo sapiens_hsa04924 | 0.46452612 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44670461 |
| 111 | Purine metabolism_Homo sapiens_hsa00230 | 0.43521230 |
| 112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43270662 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42404135 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42124620 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.39486080 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.37173662 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37093641 |
| 118 | Tight junction_Homo sapiens_hsa04530 | 0.37060397 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34859003 |
| 120 | Gap junction_Homo sapiens_hsa04540 | 0.34848252 |
| 121 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.34431581 |
| 122 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.34350283 |
| 123 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.34131551 |
| 124 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34064599 |
| 125 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.33661532 |
| 126 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33422086 |
| 127 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32827361 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32819070 |
| 129 | Prion diseases_Homo sapiens_hsa05020 | 0.32658760 |
| 130 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30423609 |
| 131 | Pertussis_Homo sapiens_hsa05133 | 0.28784199 |
| 132 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.28648612 |
| 133 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.28051746 |
| 134 | Bile secretion_Homo sapiens_hsa04976 | 0.28046740 |

